Pacific Biosciences
PACB
Pacific Biosciences (PACB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Underweight | $1.50 from $1.00 | May 11, 2026 |
| Barclays | Maintained | Underweight | $1.00 from $1.50 | Apr 14, 2026 |
| Barclays | Downgraded | Equal-Weight → Underweight | $1.50 from $2.00 | Mar 6, 2026 |
| Barclays | Maintained | Equal-Weight | $2.00 from $1.50 | Dec 15, 2025 |
| Piper Sandler | Maintained | Neutral | $2.00 from $1.50 | Nov 11, 2025 |
| Stephens & Co. | Maintained | Overweight | $2.00 from $1.80 | Nov 10, 2025 |
| Piper Sandler | Maintained | Neutral | $1.50 from $1.25 | Aug 11, 2025 |
| Barclays | Maintained | Equal-Weight | $1.50 from $2.00 | Jun 25, 2025 |
| Stephens & Co. | Maintained | Overweight | $1.80 | May 15, 2025 |
| Piper Sandler | Maintained | Neutral | $1.25 from $2.00 | May 15, 2025 |
| Canaccord Genuity | Maintained | Buy | $3.00 | Apr 10, 2025 |
| Scotiabank | Maintained | Sector Outperform | $2.00 from $6.00 | Mar 25, 2025 |
| Piper Sandler | Maintained | Neutral | $2.00 from $2.50 | Feb 20, 2025 |
| Stephens & Co. | Maintained | Overweight | $2.50 | Feb 18, 2025 |
| Goldman Sachs | Maintained | Neutral | $1.50 from $1.75 | Feb 18, 2025 |
| Stephens & Co. | Maintained | Overweight | $2.50 | Feb 14, 2025 |
| Goldman Sachs | Maintained | Neutral | $1.75 from $2.25 | Jan 23, 2025 |
| Piper Sandler | Maintained | Neutral | $2.50 from $2.00 | Nov 11, 2024 |
| Scotiabank | Maintained | Sector Outperform | $6.00 from $7.00 | Nov 11, 2024 |
| UBS | Downgraded | Buy → Neutral | $2.00 | Nov 11, 2024 |
Frequently asked questions
What is the latest analyst rating on PACB?
On May 11, 2026, Barclays maintained Pacific Biosciences at Underweight with a price target of $1.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.